What happened? Shares of healthcare services provider LifeMD (LFMD 0.57%) are plunging on Wednesday and were down by 22.3% as of 3:45 p.m. EDT. The company did not report any news, but these losses are a result of a short-seller report issued by investigative research firm Culper Research.
Full Answer
Where can I buy lifemd shares?
Apr 19, 2021 · What happenedShares of telehealth services provider LifeMD (NASDAQ: LFMD) are falling sharply on Monday and were down by 12.7% as of 1:49 p.m. EDT, after dropping by as much as 18.8% earlier in ...
What are analysts'price targets for lifemd's stock?
Apr 19, 2021 · Shares of telehealth services provider LifeMD ( NASDAQ:LFMD) are falling sharply on Monday and were down by 12.7% as of 1:49 p.m. EDT, after dropping by as much as 18.8% earlier in the day. These ...
Will lifemd’s earnings grow in the coming year?
Apr 19, 2021 · Shares of telehealth services provider LifeMD (NASDAQ: LFMD) are falling sharply on Monday and were down by 12.7% as of 1:49 p.m. EDT, after dropping by as much as 18.8% earlier in the day.
Is lifemd a good company?
Apr 02, 2022 · 3 equities research analysts have issued 1 year price targets for LifeMD's shares. Their forecasts range from $14.00 to $16.00. On average, they anticipate LifeMD's share price to reach $15.00 in the next twelve months. This suggests a possible upside of 365.8% from the stock's current price.
Is LifeMD a good stock to buy?
Valuation metrics show that LifeMD, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of LFMD, demonstrate its potential to underperform the market.
Will LifeMD stock go up?
On average, Wall Street analysts predict that LifeMD's share price could reach $15.00 by Mar 22, 2023. The average LifeMD stock price prediction forecasts a potential upside of 322.54% from the current LFMD share price of $3.55.
Why is LifeMD falling?
Specifically, Culper Research alleged that LifeMD and its executives are engaged in fraudulent and criminal business activities. Image source: Getty Images. Following the release of this report, shares of LifeMD dropped by almost 25% in one day.Apr 19, 2021
Should I buy Md stock?
LifeMD, Inc. finds support from accumulated volume at $3.07 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested. This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk".
Is LifeMD a buy right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last year. There are currently 2 buy ratin...
Are investors shorting LifeMD?
LifeMD saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 753,800 shares, a decline...
When is LifeMD's next earnings date?
LifeMD is scheduled to release its next quarterly earnings announcement on Thursday, May 12th 2022. View our earnings forecast for LifeMD .
How were LifeMD's earnings last quarter?
LifeMD, Inc. (NASDAQ:LFMD) issued its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.36) earnings per share for...
What guidance has LifeMD issued on next quarter's earnings?
LifeMD issued an update on its FY 2022 earnings guidance on Monday, March, 7th. The company provided earnings per share guidance of for the period....
What price target have analysts set for LFMD?
2 brokers have issued 12-month price targets for LifeMD's shares. Their forecasts range from $15.00 to $16.00. On average, they expect LifeMD's sto...
Who are LifeMD's key executives?
LifeMD's management team includes the following people: Justin Schreiber , Chairman & Chief Executive Officer ( LinkedIn Profile ) Alexander Mir...
Who are some of LifeMD's key competitors?
Some companies that are related to LifeMD include Teladoc Health (TDOC) , Cano Health (CANO) , 1Life Healthcare (ONEM) , Hims & Hers Health (HI...
What is LifeMD's stock symbol?
LifeMD trades on the NASDAQ under the ticker symbol "LFMD."
The company's shares are falling despite stellar preliminary first-quarter revenue results
A Fool since 2019, Prosper's writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math.
What happened
Shares of telehealth services provider LifeMD ( NASDAQ:LFMD) are falling sharply on Monday and were down by 12.7% as of 1:49 p.m. EDT, after dropping by as much as 18.8% earlier in the day.
So what
Understanding the basis for Kaskela Law's class action lawsuit requires a bit of background information. On April 14, investigative research firm Culper Research made serious accusations against LifeMD in a short-seller report.
Now what
Despite the drama linked to Culper Research's short-seller report, LifeMD's business seems to be doing well. For the first quarter, the company expects revenue of $18.2 million, which is above the consensus analyst estimate of $17.01 million. This revenue figure would also represent year-over-year top-line growth of 323%.
What is Prosper's passion?
Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math.
Does Prosper Junior Bakiny have a position in any of the stocks mentioned?
Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Is LifeMD a buy right now?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" LifeMD stock.#N#View analyst ratings for LifeMD or view top-rated stocks.
What stocks does MarketBeat like better than LifeMD?
Wall Street analysts have given LifeMD a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but LifeMD wasn't one of them.
When is LifeMD's next earnings date?
LifeMD is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.#N#View our earnings forecast for LifeMD.
How were LifeMD's earnings last quarter?
LifeMD, Inc. (NASDAQ:LFMD) issued its quarterly earnings data on Thursday, August, 12th. The company reported ($0.51) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.45) by $0.06.
What guidance has LifeMD issued on next quarter's earnings?
LifeMD issued an update on its FY 2021 earnings guidance on Thursday, September, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $90 million-$100 million, compared to the consensus revenue estimate of $92.99 million.
What price target have analysts set for LFMD?
1 Wall Street analysts have issued twelve-month price objectives for LifeMD's shares. Their forecasts range from $30.00 to $30.00. On average, they expect LifeMD's stock price to reach $30.00 in the next year.
Who are some of LifeMD's key competitors?
Some companies that are related to LifeMD include Teladoc Health (TDOC), Cano Health (CANO), 1Life Healthcare (ONEM), Hims & Hers Health (HIMS), DFP Healthcare Acquisitions (DFPH), Skylight Health Group (SLHG), Concord Medical Services (CCM) and WellQuest Medical & Wellness (WEQL).#N#View all of LFMD's competitors.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, August 17, 2021, and so far it has risen 5.43%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss
LifeMD, Inc. finds support from accumulated volume at $7.07 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is LifeMD, Inc. stock A Buy?
LifeMD, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Is the stock market forward thinking?
T hat the stock market is a forward-thinking beast is well known, but this fact has been particularly emphasized by investors during this earnings season. While many companies have delivered excellent reports, a big chunk stumbled when providing – or even deciding to not provide – the anticipated outlook. Investors have shown that what they really what to hear is not only “that was a great quarter,” but that the business has good days ahead.
Is it important to do your own analysis before investing?
It is very important to do your own analysis before making any investment. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Trending Topics. Trending Articles.
LifeMD Inc Stock Forecast
Over the next 52 weeks, LifeMD Inc has on average historically risen by 64.7 % based on the past 21 years of stock performance.
Will LifeMD Inc Stock Go Up Next Year?
Over the next 52 weeks, LifeMD Inc has on average historically risen by 64.7% based on the past 21 years of stock performance.
LifeMD Inc Stock Price History
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LFMD is experiencing slight buying pressure.
Stock Predictions
Is LifeMD Inc stock public?#N#Yes, LifeMD Inc is a publicly traded company.
